Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose Nevirapine

Esther J. Lee(Johns Hopkins University Center for AIDS Research), Rami Kantor(Johns Hopkins University Center for AIDS Research), Mary T. Bassett(Physicians for Human Rights), Patrick Mateta(University of Zimbabwe), Elizabeth Johnston(Johns Hopkins University Center for AIDS Research), David Katzenstein(Stanford University), Wayne Sheldon(Fred Hutch Cancer Center), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Samuel Adeniyi Jones(National Institutes of Health), Jennifer Wells(University of Zimbabwe), Lynn S. Zijenah(University of Zimbabwe), Christopher H. Contag(Michigan State University), Avinash K. Shetty(Wake Forest University), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Yvonne Maldonado(Palo Alto University), Hoosen Coovadia(University of KwaZulu-Natal)
The Journal of Infectious Diseases
September 8, 2005
10.1086/444424
Cited by 62

Related Papers

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
|BMJ|2020|2.4k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Therapy for HIV Infection in 1998
|JAMA|1998|1k